Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth

Autor: Konstantinos Kamposioras, Davide Mauri, Konstantinos Papadimitriou, Alan Anthoney, Nadia Hindi, Branka Petricevic, Mario Dambrosio, Antonis Valachis, Pantelis Kountourakis, Jindrich Kopecky, Cvetka Grašič Kuhar, Lazar Popovic, Nataliya P. Chilingirova, George Zarkavelis, Ramon Andrade de Mello, Natalija Dedić Plavetić, Christos Christopoulos, Bianca Mostert, John R. Goffin, Dimitiros Tzachanis, Haytham Hamed Saraireh, Fei Ma, Ida Pavese, Maria Tolia

Publikováno v: Frontiers in oncology
Digital.CSIC. Repositorio Institucional del CSIC
instname
Frontiers in Oncology
Frontiers in Oncology, 10:575148. Frontiers Media S.A.
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Frontiers in Oncology, Vol 10 (2020)

Introduction: Pandemic COVID-19 is an unexpected challenge for the oncological community, indicating potential detrimental effects on cancer patients. Our aim was to summarize the converging key points providing a general guidance in order to support

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8132faa22d2b7c1d1e5da6a705e76dc0
https://doi.org/10.3389/fonc.2020.575148

Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.

Autor: Serafini MS; Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Cavalieri S; Head and Neck Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy., Licitra L; Head and Neck Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy., Pistore F; Head and Neck Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy., Lenoci D; Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Canevari S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Airoldi M; Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Cossu Rocca M; European Institute of Oncology, Milano, Italy., Strojan P; University of Ljubljana, Ljubljana, Slovenia., Kuhar CG; University of Ljubljana, Ljubljana, Slovenia.; Institute of Oncology, Ljubljana, Slovenia., Merlano M; Candiolo Cancer Institute, Candiolo, Italy., Perrone F; Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vingiani A; Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy.; Department of Diagnostic Pathology and Laboratory, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Denaro N; Medical Oncology, ARCO Foundation, Cuneo, Italy., Perri F; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Argiris A; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Gurizzan C; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy., Ghi MG; Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy., Cassano A; Policlinico Universitario Agostino Gemelli Dipartimento di scienze mediche e chirurgiche, Roma, Italy., Allegrini G; Azienda USL Toscana nord ovest Sede di Livorno, Pisa, Italy., Bossi P; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy., De Cecco L; Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy loris.dececco@istitutotumori.mi.it.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jan 30; Vol. 12 (1). Date of Electronic Publication: 2024 Jan 30.

Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer.

Autor: Kuhar CG; Institute of Oncology Ljubljana, Department of Medical Oncology, Zaloška 2, 1000, Ljubljana, Slovenia; Faculty of Medicine Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia., Borštnar S; Institute of Oncology Ljubljana, Department of Medical Oncology, Zaloška 2, 1000, Ljubljana, Slovenia; Faculty of Medicine Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia., Gazić B; Faculty of Medicine Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia; Institute of Oncology Ljubljana, Department of Pathology, Zaloška 2, 1000, Ljubljana, Slovenia., Matos E; Institute of Oncology Ljubljana, Department of Medical Oncology, Zaloška 2, 1000, Ljubljana, Slovenia; Faculty of Medicine Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia. Electronic address: ematos@onko-i.si.

Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2023 Jun; Vol. 69, pp. 481-490. Date of Electronic Publication: 2023 Jan 24.

COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information.

Autor: Mauri D; Department Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Kamposioras K; Department. Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Tsali L; PACMeR Evidence Based Medicine, Athens, Greece., Dambrosio M; Department. Medical Oncology, Clinica San Carlo, Paderno Dugnano, Milano Italy., De Bari B; Service Radio-Oncologie Neuchâtel Hôpital Network, La Chaux-de-Fonds, Switzerland., Hindi N; Department. Medical Oncology, Fundación Jimenez Díaz University Hospital, Madrid, Spain., Salembier C; Radiation Oncology Department, Europe Hospitals, Brussels, Belgium., Nixon J; Beatson West of Scotland Cancer Center, Strathclyde University, Glasgow, UK., Dimitrios T; UCSD Blood and Marrow Transplant Program, UCSD/Moores Cancer Center, La Jolla, CA, USA., Alongi F; Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria, Negrar-Verona,University of Brescia, Verona, Italy., Hameed H; The Christie NHS Foundation Trust, Manchester UK, The Christie\'s Hospital, Manchester, UK., Valachis A; Department Medical Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Antonios, Sweden., Papadimitriou K; Department of Medical Oncology, University Hospital of Antwerp, Antwerp, Belgium., Corradini S; Department Radiation Oncology, University Hospital, LMU Munich, Germany., Popovic L; Department Medical Oncology,Oncology Institute of Vojvodina, University of Novi Sad, Serbia., Kopecky J; Department Oncology and Radiotherapy, Charles University, Hradec Králové, Prague, Czech Republic., Rodriguez A; Medical Oncology, Instituto Alexander Fleming in Buenos Aires, Buenos Aires, Argentina., Antunac K; University Hospital for Tumors, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia., Yi J; Department Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China., Lovey J; National Institute of Oncology, Semmelweis University, Budapest, Hungary., Strojan P; Department Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia., Saraireh H; Department Radiation Oncology, Royal Medical Service, Amman, Jordan., Røtterud R; Cell Biologist, CEO Bladder Cancer, Oslo, Norway., Chojnacka M; Department of Oncology and Radiotherapy, Maria Skłodowska- Curie National Research Institute of Oncology, Warsaw, Poland., Olalla SC; Service de Radio-Oncologie, Neuchâtel Hôpital Network, La Chaux-de-Fonds, Switzerland., Chilingirova N; Department Medical Oncology, Center of Excellence, Heart and Brain Hospital Pleven, Medical University Pleven, Bulgaria., De Mello RA; Department Medical Oncology Escola Paulista de Medicina, Federal University of São Paulo, Brazil.; Department Biomedical Sciences,and Medicine, University of Algarve, Faro, Portugal., Amaral GA; Department Medical Oncology, Escola Paulista de Medicina, Federal University of São Paulo, Brazil., Arbabi F; Department Medical Oncology, Rooshana Cancer Center, Tehran, Iran., Vidra R; Medical Oncology, Regional Institute of Gastroenterology and Hepatology 'Prof. Dr. O. Fodor', Cluj-Napoca, Romania., Rapushi E; Department Medical Oncology, Berat Regional Hospital, Berat, Albania., Takeuchi D; Matsudo City General Hospital, Chiba, Japan., Christopoulos C; Service de Radiothérapie Oncologique, GHT Grand Paris Nord-Est. G.H.I Le Raincy -Montfermeil, France., Ivanova I; Murmansk Branch of All-Russian Association of Cancer Patients 'Zdravstvuy', NGO Center of Initiatives Support, Murmansk, Russia., Djan I; Department for Radiosurgery and SBRT, Clinical center of Serbia, Belgrade, Serbia., Petricevic B; Department of Medical Oncology and Hematology,Wilhelminenspital, Vienna, Austria., Cellini F; Radioterapia Oncologica-Fondazione Policlinico A. Gemelli, IRCCS -Rome, Italy., Mihaylova I; Department of Radiotherapy,Specialized Hospital for Active Treatment in Oncology 'Plovdivsko pole', Sofia, Bulgaria., Plavetic ND; Department of Oncology, University Hospital Centre Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia., Kuhar CG; Department Medical Oncology, Institute of Oncology, Ljubljana, Slovenia., Takeuchi E; The Christie NHS Foundation Trust, Manchester, UK., Kountourakis P; Department Medical Oncology,Bank of Cyprus Oncology Centre, Nicosia, Cyprus., Ntellas P; Department Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Gazouli I; Department Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Gkoura S; Department Medical Oncology, University Hospital of Ioannina, Ioannina, Greece., Yuce S; Chairmen of the Board-Young Saving Association, Turkey., Er Ö; Acıbadem University, Faculty of Medicine, Turkey., Yasmina C; Service de Haematologie, GHT Grand Paris Nord-Est. G.H.I Le Raincy -Montfermeil, France GHT Grand Paris Nord-Est, G.H.I Le Raincy -Montfermeil, France., Kumaran G; Medical Oncology, Auckland Regional Cancer and Blood Service, Auckland, New Zealand., Spahiu O; Radiation Therapy Unit, University Hospital Center 'Mother Teresa', Tirana, Albania., Yusuf A; Gastroenterology, Acting CEO Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore and Peshawar Pakistan., Gono P; ECPC Partneships and Communication Officer, Belgium., Apostolidis K; ECPC President ,Belgium., Tolia M; Department. Radiation Oncology, University Hospital of Heraklion, Crete, Greece.

Publikováno v: Reviews on recent clinical trials [Rev Recent Clin Trials] 2022; Vol. 17 (1), pp. 11-14.